Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 12, pp. 1542-1553
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 26, 2020
- Revision received July 7, 2020
- Accepted October 14, 2020
- Published first October 22, 2020.
Article Versions
- Previous version (October 22, 2020 - 06:11).
- Previous version (November 11, 2020 - 06:00).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Saeed S. Akhand1,
- Zian Liu1,
- Stephen C. Purdy1,
- Ammara Abdullah1,
- Hang Lin1,
- Gregory M. Cresswell2,
- Timothy L. Ratliff2,3, and
- Michael Wendt1,3,*
- 1Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana.
- 2Department of Comparative Pathobiology, Purdue University, West Lafayette, Indiana.
- 3Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana.
- ↵*Corresponding Author:
Michael Wendt, Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 201 South University Street, Hansen Life Sciences Building, West Lafayette, IN 47907. Phone: 765-494-0860; Fax: 765-494-1414; E-mail: mwendt{at}purdue.edu
December 2020
Volume 8, Issue 12
Volume 8, Issue 12
Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade
Jump to section
Advertisement